There’s two ways of looking at this …
They wanted to give an opportunity for long term shareholders to participate at a low cost as this will be the last chance before the interim results are known.
If successful …
At that point it will no longer be shareholders funding any further .
It’s good to know …. In March 2024, the Company updated the market to report that 11 patients had
been dosed in the Phase 2a trial at that time
.
There’s two ways of looking at this … They wanted to give an...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.8¢ |
Change
0.003(1.06%) |
Mkt cap ! $114.3M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 22.5¢ | $1.377M | 5.904M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 220005 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 1115446 | 12 |
View Market Depth
| Last trade - 12.50pm 30/07/2025 (20 minute delay) ? |
| ATX (ASX) Chart |